TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination (original) (raw)
References
Raine, C.S. The immunology of the multiple sclerosis lesion [The Dale E. McFarlin memorial lecture]. Ann. Neurol.36, S61–S72 (1994). ArticleCAS Google Scholar
Bernard, C.C.A. & Kerlero de Rosbo, N. Multiple sclerosis: An autoimmune disease of multifactorial etiology. Curr. Opin. Cell Biol.4, 760–765 (1992). ArticleCAS Google Scholar
Merrill, J.E. & Benveniste, E.N. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci.19, 331–338 (1996). ArticleCAS Google Scholar
Navikas, V. & Link, H. Cytokines and the pathogenesis of multiple sclerosis [Review]. J. Neurosci. Res.45, 322–333 (1996). ArticleCAS Google Scholar
Selmaj, K., Papierz, W., Glabinski, A. & Kohno, T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol.56, 135–141 (1995). ArticleCAS Google Scholar
Bernard, C.C.A., et al. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis. J. Mol. Med.75, 77–88 (1997). ArticleCAS Google Scholar
Marino, M.W., et al. Characterization of tumor necrosis factor deficient mice. Proc. Natl. Acad. Sci. USA94, 8093–8098 (1997). ArticleCAS Google Scholar
Aggarwal, B.B. & Natarajan, K. Tumor necrosis factor: Developments during the last decade. Eur. Cytokine Netw.7; 93–124 (1996). CASPubMed Google Scholar
Ruddle, N.H. et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med.172, 1193–1200 (1990). ArticleCAS Google Scholar
Willenborg, D.O., Fordham, S., Bernard, C.C.A., Cowden, W.B. & Ramshaw, I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocy glycoprotein-induced autoimmune encephalomyelitis. J. Immunol.157, 3223–3227 (1996). CASPubMed Google Scholar
Ichikawa, M., Johns, T.G., Liu, J. & Bernard, C.C.A. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35–55. J. Immunol.157, 919–926 (1996). CASPubMed Google Scholar
Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflammatory responses in TNFα-deficient mice: A critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med.184, 1397–1411 (1996). ArticleCAS Google Scholar
Linington, C., et al. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol.23, 1364–1371 (1993). ArticleCAS Google Scholar
Sercarz, E.E., et al. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol.11, 729–766 (1993). ArticleCAS Google Scholar
Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T. & Brosnan, C.F. Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J. Immunol.147, 1522–1529 (1991). CASPubMed Google Scholar
Sharief, M.K. & Hentges, R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med.325, 467–472 (1991). ArticleCAS Google Scholar
Paya, C.V., Leibson, P.J., Patrick, A.K. & Rodriguez, M. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor-α. Int. Immunol.2, 909–913 (1990). ArticleCAS Google Scholar
Jacob, C.O. & McDevitt, H.O. Tumour necrosis factor-α in murine autoimmune ‘lupus’ nephritis. Nature, 331, 356–358 (1988). ArticleCAS Google Scholar
Jacob, C.O., Aiso, S., Michie, S.A., McDevitt, H.O. & Acha-Orbea, H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-α and interleukin 1. Proc. Natl. Acad. Sci. USA87, 968–972 (1990). ArticleCAS Google Scholar
Bruce, A.J., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med.2, 788–794 (1996). ArticleCAS Google Scholar
Rothwell, N.J. & Luheshi, G.N. Brain TNF: Damage limitation or damaged reputation? Nature Med.2, 746–747 (1996). ArticleCAS Google Scholar
Liu, Z., Hsu, H., Goeddel, D.V. & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell87, 565–576 (1996). ArticleCAS Google Scholar
Eugster, H-P., et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice. Int. Immunol.8, 23–36 (1996). ArticleCAS Google Scholar
Lewis, M., et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA88, 2830–2834 (1991). ArticleCAS Google Scholar
Vanoosten, B.W., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody CA2. Neurology47, 1531–1534 (1996). ArticleCAS Google Scholar
Jayaram, B.M., Menon, K.K., Slavin, A., Reid, H. & Bernard, C.C.A. Purification of human myelin oligodendrocyte glycoprotein (MOG) produced in bacteria and Sf9 insect cells [Abstr.]. J. Neurochem.66, S41 (1996). Google Scholar